Professional Overview
Michael Gaisford is a seasoned executive currently serving as CEO at Intera Oncology Inc., located in Wellesley, Massachusetts, United States. His key expertise areas include marketing, healthcare solutions, medical devices, and leadership, with a strong industry focus on oncology and medical technology.
Experience Summary
Current Role
As the CEO of Intera Oncology Inc., Michael oversees the strategic direction and overall operations of the company. His key responsibilities include driving business growth, leading cross-functional teams, and fostering innovative solutions in the field of oncology. Under his leadership, the company has been positioned for significant advancements in cancer treatment technologies.
Career Progression
Michael's career progression is marked by notable roles at prominent companies such as Stratasys and Boston Scientific. At Stratasys, he held positions including Director of Marketing, Healthcare Solutions, and Director of Marketing, Medical Solutions, from 2015 to 2019. Prior to Stratasys, Michael spent several years at Boston Scientific, where he served in various capacities including Senior Manager, Productivity Office; Group Marketing Manager, Electrophysiology; and Senior Product Manager, Electrophysiology, from 2008 to 2015. These roles have provided him with a deep understanding of the medical device industry and the ability to navigate complex healthcare markets.
Areas of Expertise
Michael's expertise encompasses industry-specific skills in medical device marketing, healthcare solutions, and oncology. He possesses technical competencies in product management, marketing strategy, and team leadership. His leadership and management capabilities are underscored by his ability to drive growth, lead cross-functional teams, and innovate within highly regulated industries.
Professional Impact
Throughout his career, Michael has been involved in numerous projects and initiatives aimed at advancing medical technology and improving patient outcomes. His contributions to the field of oncology, in particular, have been significant, with a focus on innovative solutions and strategic leadership.
Conclusion
Michael Gaisford's professional trajectory is marked by consistent growth, strategic leadership, and a commitment to innovation in the medical technology sector. Currently, as CEO of Intera Oncology Inc., he is focused on driving the company's mission to advance cancer treatment through cutting-edge technologies. His value proposition lies in his unique blend of industry expertise, leadership acumen, and passion for improving healthcare outcomes.
